Evidence map›Paper›PMID 34588926›Full record

ReviewPathology oncology research : POR2021

The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis.

Muhammad Ihtisham Umar, Waseem Hassan, Ghulam Murtaza, Manal Buabeid, Elshaimaa Arafa, Hafiz Muhammad Irfan, Mohd Zaini Asmawi, Xianju Huang

Abstract readReview
In one paragraph

Review in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Current and future therapies for small cell lung carcinoma.Journal of hematology & oncology · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Muhammad Ihtisham UmarDepartment of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan.
Waseem HassanDepartment of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan.
Ghulam MurtazaDepartment of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan.
Manal BuabeidDepartment of Clinical Sciences, Ajman University, Ajman, United Arab Emirates.
Elshaimaa ArafaDepartment of Clinical Sciences, Ajman University, Ajman, United Arab Emirates.
Hafiz Muhammad IrfanDepartment of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Mohd Zaini AsmawiSchool of Pharmaceutical Sciences, University of Science Malaysia, Pulau Pinang, Malaysia.
Xianju HuangCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hormonal imbalance may disrupt the rigorously monitored cellular microenvironment by hampering the natural homeostatic mechanisms. The most common example of such hormonal glitch could be seen in obesity where the uprise in adipokine levels is in virtue of the expanding bulk of adipose tissue. Such aberrant endocrine signaling disrupts the regulation of cellular fate, rendering the cells to live in a tumor supportive microenvironment. Previously, it was believed that the adipokines support cancer proliferation and metastasis with no direct involvement in neoplastic transformations and tumorigenesis. However, the recent studies have reported discrete mechanisms that establish the direct involvement of adipokine signaling in tumorigenesis. Moreover, the individual adipokine profile of the patients has never been considered in the prognosis and staging of the disease. Hence, the present manuscript has focused on the reported extensive mechanisms that culminate the basis of poor prognosis and diminished survival rate in obese cancer patients.

Indexed as

AdipokinesCell ProliferationCell SurvivalCell Transformation, NeoplasticHumansNeoplasmsTumor MicroenvironmentAdipokinesadipokinescell cycleleptin signalingmesenchymal transitionobesity derived cancers

Identifiers

PMID34588926
PMCPMC8473628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.